Design and characterisation of an amorphous formulation of nifedipine for the treatment of autonomic dysreflexia.

Published in: The Journal of pharmacy and pharmacology (2021)

This study demonstrates that a nifedipine-PVP ASD is a promising formulation strategy in the treatment of AD.

Keyphrases